| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/08/2009 | EP2044083A1 Antiviral agents |
| 04/08/2009 | EP2044077A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 04/08/2009 | EP2044066A2 Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide |
| 04/08/2009 | EP2044047A1 Naphthofuranone derivatives as specific inhibitors of thymidylate synthases |
| 04/08/2009 | EP2044032A2 Novel inhibitors of hepatitis c virus replication |
| 04/08/2009 | EP2043690A1 Use of alpha-toxin for treating and preventing staphylococcus infections |
| 04/08/2009 | EP2043661A1 Use of tylvalosin as antiviral agent |
| 04/08/2009 | EP2043658A2 Antiviral phosphinate compounds |
| 04/08/2009 | EP2043657A2 Use of stilbene derivatives for treatment and prevention of aquatic mold infections |
| 04/08/2009 | EP2043653A2 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
| 04/08/2009 | EP2043636A2 (combi) compositions for the treatment of mucormycosis comprising iron chelator and antifungal agent |
| 04/08/2009 | EP1970061A4 Medicinal agent for treating viral infections |
| 04/08/2009 | EP1706114A4 Chemical inhibitors of soluble adenylyl cyclase (sac) |
| 04/08/2009 | EP1634590A4 Coronavirus inactivating agent |
| 04/08/2009 | EP1630160B1 The isoflavone derivatives of tectoridin, the preparation thereof and the anti-virus medicines containing the same as the effective constituents |
| 04/08/2009 | EP1539808B1 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 04/08/2009 | EP1501921B1 Improved viral purification methods |
| 04/08/2009 | EP1476468B9 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | EP1430023B1 Substituied urea retinoid agonists ii |
| 04/08/2009 | EP1309355B9 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 04/08/2009 | EP1235589B1 Compositions comprising neisseria meningitidis antigens from serogroups b and c as well as a further antigen |
| 04/08/2009 | CN101405300A Methods and compositions for antagonism of RAGE |
| 04/08/2009 | CN101405283A HIV inhibiting 5-amido substituted pyrimidines |
| 04/08/2009 | CN101405277A Dicarbonylic compounds with antibacterial activity |
| 04/08/2009 | CN101405032A Anti-infective solution comprising a compound of pyrido(3,2,1-ij)-benzoxadiazine type |
| 04/08/2009 | CN101405010A 避孕组合物 Contraceptive composition |
| 04/08/2009 | CN101404986A Methods of use and compositions for the diagnosis and treatment of infectious disease |
| 04/08/2009 | CN101402961A Method for producing glucoprotein vaccine |
| 04/08/2009 | CN101402944A EV-71 virus seed, inactivated vaccine for human and method of producing the same |
| 04/08/2009 | CN101402909A Sunflower alcohol |
| 04/08/2009 | CN101402736A Biodegradable unsaturated polyphosphate, preparation and use method thereof |
| 04/08/2009 | CN101402677A Quadrant peptide and uses thereof |
| 04/08/2009 | CN101402676A Polyglycols modified disinfection/neutralization endotoxin polypeptide, preparation and uses thereof |
| 04/08/2009 | CN101402666A Saponin with immunoadjuvant function, preparation method, vaccine preparation containing the saponin as adjuvant and uses thereof |
| 04/08/2009 | CN101402613A Substituted phenoxy oxygen alkylamine triazole alcohol antimycotic compounds and method of preparing the same |
| 04/08/2009 | CN101401939A Anti-activated state T cell antibody vaccine for preventing and/or treating immune correlated disease |
| 04/08/2009 | CN101401937A Method of preparing coexpression PRRSV ORF5 and ORF6 double-gene nucleic acid vaccine |
| 04/08/2009 | CN101401936A Method of preparing coexpression PRRSV ORF5 and PCV2 ORF2 bivalent nucleic acid vaccine |
| 04/08/2009 | CN101401935A Astragalus polysaccharide adjuvant and uses in type I riemerella anatipestifer inactivated vaccine |
| 04/08/2009 | CN101401934A T cell component vaccine for preventing and/or treating immune correlated diseases |
| 04/08/2009 | CN101401931A Detergent for removing dermatophytosis and abnormal smell of body |
| 04/08/2009 | CN101401881A Chinese medicinal composition for treating poison produced by venomous insects |
| 04/08/2009 | CN101401867A Coating medicine for treating dermatophytosis |
| 04/08/2009 | CN101401863A Traditional Chinese medicine bactericide for condom |
| 04/08/2009 | CN101401861A Traditional Chinese medicine prescription for treating damp-heat dysentery |
| 04/08/2009 | CN101401859A Fever-lowering medicament for clearing heat and detoxication |
| 04/08/2009 | CN101401848A Composition for treating acute, chronic hepatitis and fatty liver |
| 04/08/2009 | CN101401847A Medicament composition containing lamivudine |
| 04/08/2009 | CN101401822A General medicinal powder for treating beriberi, foot corn and callus on the sole |
| 04/08/2009 | CN101401814A Orally taken medicament formulation of clindamycin phosphate and preparing method thereof |
| 04/08/2009 | CN101401812A Tigecycline freeze-dried injection |
| 04/08/2009 | CN101401810A Dispersible tablet containing Cefixime and preparation method thereof |
| 04/08/2009 | CN101401807A Uses of selective JAK3 restrainer VI in antiviral mediated acute lung damnification |
| 04/08/2009 | CN101401790A Lavo-ofloxacin liposome and preparation method thereof |
| 04/08/2009 | CN101401787A Ceftiofur long-acting injection and preparation method thereof |
| 04/08/2009 | CN101401592A Extracting method for kuh-seng disinfection composition and sanitizer containing the kuh-seng disinfection composition |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475840C Wasp antibiotic peptide and preparing method and use thereof |
| 04/08/2009 | CN100475839C Inhibition peptide in domain of polymerase protein of hepatitis b virus, and application |
| 04/08/2009 | CN100475825C Acyclic nucleoside phosphonate derivatives |
| 04/08/2009 | CN100475822C Synthesis method for producing ecteinascidin compound |
| 04/08/2009 | CN100475819C Pseudopolymorphic forms of a HIV protease inhibitor |
| 04/08/2009 | CN100475817C Crystal of 1-methyl carbapenem compound |
| 04/08/2009 | CN100475815C HIV-reproduction-inhibitive purinderivater |
| 04/08/2009 | CN100475262C Liver-soothing and qi-dispersing medicine for preventing and treating SARS and viral hepatitis complication |
| 04/08/2009 | CN100475238C Medication for HIV and manufacturing process thereof |
| 04/08/2009 | CN100475237C External application medicine powder for treating dermatophytosis |
| 04/08/2009 | CN100475223C Medicament box used for treating acute anhelation syndrome |
| 04/08/2009 | CN100475218C Blattbulume extract, prepn process and application thereof |
| 04/08/2009 | CN100475215C Cefuroxime axetil taste masking pellet and method of preparing the same |
| 04/08/2009 | CN100475211C Oral itraconazole composition being not affected by ingested food and process for preparing same |
| 04/08/2009 | CN100475209C Anti-coronavirus drug |
| 04/08/2009 | CN100475206C Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/08/2009 | CN100475202C Medicinal composition with function of clearing away heat and toxic material |
| 04/08/2009 | CN100475191C Pure fruit juice possessing anti inflammation, disinfactant and antivirus functions |
| 04/08/2009 | CN100475182C Composition for preventive treatment of herpessimplex |
| 04/07/2009 | US7514571 Bicyclo derivative |
| 04/07/2009 | US7514565 3,5-Difluoropyridines |
| 04/07/2009 | US7514564 Substituted amine derivatives and methods of use |
| 04/07/2009 | US7514547 Helicobacter felis vaccine |
| 04/07/2009 | US7514541 crosslinking with curing agents in acidic or alkaline conditions, to form to products used in cosmetic, medical and pharmaceutical applications |
| 04/07/2009 | US7514535 Chimeric immunogens |
| 04/07/2009 | US7514469 Cyclooxygenase inhibitors; osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse |
| 04/07/2009 | US7514456 Nicotinamide derivatives useful as p38 inhibitors |
| 04/07/2009 | US7514451 1 -cyclopropyl-7- [3-cyclopropylaminomethyl-4-fluoro-1 -pyrrolidinyl]-6-fluoro -1 ,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylic acid; bactericide; against drug-resistant bacteria and against gram-positive bacteria, such as MRSA, PRSP and VRE |
| 04/07/2009 | US7514445 Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors) |
| 04/07/2009 | US7514397 Administering homologs of peptides corresponding to amino acid residues 638 to 673, and to amino acid residues 558 to 595, of the human immunodeficiency virus-1LAI transmembrane protein glycoprotein 41; inhibiting membrane fusion |
| 04/07/2009 | US7514259 Derived from the neuroretina of the eye ex vivo and in vivo |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514105 Bioavailability/bioefficacy enhancing activity of Cuminum cyminum and extracts and fractions thereof |
| 04/07/2009 | US7514087 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 04/07/2009 | US7514086 Peptide-based vaccine for influenza |
| 04/07/2009 | US7514073 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 04/07/2009 | CA2517622C Veterinary compositions for treating mastitis |
| 04/07/2009 | CA2502103C Colon cleansing compositions |
| 04/07/2009 | CA2493633C Kinase inhibitors |
| 04/07/2009 | CA2463294C Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/07/2009 | CA2458684C Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 04/07/2009 | CA2410065C Micellar pharmaceutical compositions for buccal and pulmonary application |